Alexander E. Ivliev

577 total citations
10 papers, 404 citations indexed

About

Alexander E. Ivliev is a scholar working on Molecular Biology, Hematology and Neurology. According to data from OpenAlex, Alexander E. Ivliev has authored 10 papers receiving a total of 404 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 2 papers in Hematology and 1 paper in Neurology. Recurrent topics in Alexander E. Ivliev's work include Bioinformatics and Genomic Networks (4 papers), Gene expression and cancer classification (3 papers) and Acute Myeloid Leukemia Research (2 papers). Alexander E. Ivliev is often cited by papers focused on Bioinformatics and Genomic Networks (4 papers), Gene expression and cancer classification (3 papers) and Acute Myeloid Leukemia Research (2 papers). Alexander E. Ivliev collaborates with scholars based in United States, Russia and Netherlands. Alexander E. Ivliev's co-authors include Marina G. Sergeeva, Peter A.C. ’t Hoen, Yuri Nikolsky, Marina Bessarabova, Lee Lancashire, Dorothea Emig, Svetlana Bureeva, Willeke van Roon‐Mom, Dorien J.M. Peters and J. William Langston and has published in prestigious journals such as Blood, PLoS ONE and Cancer Research.

In The Last Decade

Alexander E. Ivliev

8 papers receiving 392 citations

Peers

Alexander E. Ivliev
Alexander E. Ivliev
Citations per year, relative to Alexander E. Ivliev Alexander E. Ivliev (= 1×) peers Kristoffer Rapacki

Countries citing papers authored by Alexander E. Ivliev

Since Specialization
Citations

This map shows the geographic impact of Alexander E. Ivliev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander E. Ivliev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander E. Ivliev more than expected).

Fields of papers citing papers by Alexander E. Ivliev

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander E. Ivliev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander E. Ivliev. The network helps show where Alexander E. Ivliev may publish in the future.

Co-authorship network of co-authors of Alexander E. Ivliev

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander E. Ivliev. A scholar is included among the top collaborators of Alexander E. Ivliev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander E. Ivliev. Alexander E. Ivliev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Haines, Eric, Víctor R. De Jesús, Daniel Hidalgo, et al.. (2026). The MEK–RAF molecular glue IK-595 has potent antitumor activity across RAS/MAPK pathway-altered cancers. Nature Cancer. 7(1). 116–130.
2.
Thomas, Michael P., Alexander E. Ivliev, Jesper L.V. Mååg, et al.. (2025). Abstract 1658: REM-422, a first-in-class mRNA degrader of the MYB oncogene, demonstrates anti-tumor activity in xenograft models of adenoid cystic carcinoma and acute myeloid leukemia. Cancer Research. 85(8_Supplement_1). 1658–1658.
3.
Thomas, Michael, Alexander E. Ivliev, Adam Štefek, et al.. (2024). REM-422, a Small Molecule MYB mRNA Degrader, Demonstrates Anti-Leukemic Activity As Monotherapy and in Combination with Standards of Care in Preclinical Models of AML. Blood. 144(Supplement 1). 826–826. 1 indexed citations
4.
Tříska, Martin, Alexander E. Ivliev, Yuri Nikolsky, & Tatiana V. Tatarinova. (2017). Analysis of cis-Regulatory Elements in Gene Co-expression Networks in Cancer. Methods in molecular biology. 1613. 291–310. 8 indexed citations
5.
Ivliev, Alexander E., Peter A.C. ’t Hoen, Dmitrii Borisevich, Yuri Nikolsky, & Marina G. Sergeeva. (2016). Drug Repositioning through Systematic Mining of Gene Coexpression Networks in Cancer. PLoS ONE. 11(11). e0165059–e0165059. 19 indexed citations
6.
Riley, Brigit E., Shyra J. Gardai, Dorothea Emig-Agius, et al.. (2014). Systems-Based Analyses of Brain Regions Functionally Impacted in Parkinson's Disease Reveals Underlying Causal Mechanisms. PLoS ONE. 9(8). e102909–e102909. 65 indexed citations
7.
Emig, Dorothea, Alexander E. Ivliev, Lee Lancashire, et al.. (2013). Drug Target Prediction and Repositioning Using an Integrated Network-Based Approach. PLoS ONE. 8(4). e60618–e60618. 172 indexed citations
8.
Ivliev, Alexander E., Peter A.C. ’t Hoen, Willeke van Roon‐Mom, Dorien J.M. Peters, & Marina G. Sergeeva. (2012). Exploring the Transcriptome of Ciliated Cells Using In Silico Dissection of Human Tissues. PLoS ONE. 7(4). e35618–e35618. 56 indexed citations
9.
Ivliev, Alexander E., Peter A.C. ’t Hoen, & Marina G. Sergeeva. (2010). Coexpression Network Analysis Identifies Transcriptional Modules Related to Proastrocytic Differentiation and Sprouty Signaling in Glioma. Cancer Research. 70(24). 10060–10070. 79 indexed citations
10.
Ivliev, Alexander E. & Marina G. Sergeeva. (2008). ORTHOFOCUS: PROGRAM FOR IDENTIFICATION OF ORTHOLOGS IN MULTIPLE GENOMES IN FAMILY-FOCUSED STUDIES. Journal of Bioinformatics and Computational Biology. 6(4). 811–824. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026